Certainly fair enough.
Yes, you're right, I don't think
Certainly fair enough.
Yes, you're right, I don't think much of Mr. Bordynuik's process and catalyst. I'm certain there's only one reason why he would withhold the results of how well a processor can transform plastic into something useful, especially when disclosing positive results would make financing cheap.
Actually Mr. Bordynuik did disclose positive results in the past and that did make financing cheap...the only problem was that those results were fake. When people heard <$10/bbl and sales of WTI-$3, the money flowed into PTOI like water...until years of excuses made most shareholders say, "Wait a minute...."
Plastic2Oil, Inc. (PTOI) Stock Research Links
Yes, I understand your penny stock also is the real deal, created with the inventiveness of Edison and destined to be the next Microsoft. Yes, I understand that the delays are also only because your company is making their product and/or technology even more revolutionary.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Anticipation Builds for Borr Drilling's Q3 Reveal Sit tight, investors. Borr Drilling Limited is set to drop its Q3 2026 financial results soon—right in the sweet spot post-market close on November 18. These moments are where fortunes are made or broken, and Borr's gearheads better be ready to spill the beans on how their offshore ventures fared in the rocky sea of...
Continue Reading
From Cultural Riches to Industrial Powerhouse Ever been to Cangzhou? No? Well, the folks there want to change that narrative pronto. This coastal gem in northern China is throwing open its doors to the global media with a big ol’ invitation to see, explore, and spread the word about what makes this city tick. Part of the Seventh World Media Summit held in Beijing, this...
Continue Reading
Celebrating a Decade of Employee Satisfaction Nailing that balance between growth and nurturing a quality workplace—now that's a hard row to hoe for many giants. Yet, United Community has strutted down this path for ten years straight, landing them again on American Banker's 'Best Banks to Work For' list. That kind of consistency screams commitment, don't it? But what's...
Continue Reading
CVRx in the Crosshairs: Legal and Operational Woes There's a storm brewing over at CVRx, Inc. (NASDAQ: CVRX), and it's pulling investors down a hell of a financial rabbit hole. You might think you're in the clear with a company like CVRx that boasts approved devices, but think again. Recent revelations have shown that even those with FDA stamps aren't immune to the...
Continue Reading
Stockholders Battle Erupts: Coastal Financial's Crisis Just when you think you've seen it all in this chaotic market, something like Coastal Financial Corporation's troubles hits you on a Tuesday afternoon like a sucker punch. If you've been dabbling with NASDAQ: CCB shares, heads-up—there's a December 1, 2026 deadline to potentially take the helm in a class action...
Continue Reading
Nuix Shakes Things Up with New Leadership Nuix, a notable player in the investigative analytics and intelligence software space, just leveled up its game by bringing in Lori Cornmesser as the Global Vice President, Partner Ecosystems. This ain't your average hire. Cornmesser's been around the block—over 25 years, in fact—building and leading partner ecosystems...
Continue Reading
Shakeup at Millrose Properties: Investor Alert! Alright, folks, gather around. We got a situation brewing with Millrose Properties, Inc. (NYSE: MRP) that's catching the attention of anyone who's hauled their portfolio through the storms and sunshine of the stock market. A class action lawsuit's knocking at the door, and any daydreaming investor who snatched up shares...
Continue Reading
Pioneering the Path to Pharma-Grade Polynucleotides In a move that's caught the attention of industry eyes, HTL Biotechnology has taken a hefty €15 million plunge into their latest production facility, HTL8, nestled in Javené, France. They've got this penchant for leading the pack in pharmaceutical-grade biopolymers and now they've thrown another log onto the fire with...
Continue Reading
CytoSorbents' Financial Turnaround Imagine the smell of fresh opportunity wafting through CytoSorbents’ (NASDAQ:CTSO) corridors this quarter. The company just nudged into positive territory with its operating cash flow, which, let’s be honest, is like finding a nugget of gold amid last year’s rubble of losses. With $43,000 of positive operating cash flow in a world...
Continue Reading
ISSA Career Connect Gains Industry Recognition In a world where finding that first job post-certification can be as brutal as a spin class in August, ISSA Career Connect seems to be offering a bit of a lifeline. This platform, already making some serious noise in the fitness industry, has just snagged a place as a finalist for App of the Year at the 2026 Beyond Activ...
Continue Reading
Top 5 Most Recently Viewed Articles
Tesla's Commitment to Community Support During Wildfires Tesla Inc (NASDAQ: TSLA) has recently made headlines for its proactive measures in response to wildfires devastating parts of California. CEO Elon Musk announced that the company's efforts would impact the delivery of Cybertrucks, which are highly anticipated by customers in the affected areas. The decision to delay...
Continue Reading
Aegon's Impressive Performance in the Third Quarter Aegon has recently shared compelling updates about its performance in the third quarter of 2024, showcasing resilience and strategic growth plans despite fluctuating market conditions. The company reported an impressive operating capital generation of EUR 336 million, which reinforces its robust financial position and...
Continue Reading
Earnings Projection for Ribbon Communications Ribbon Communications (NASDAQ:RBBN) is gearing up to unveil its quarterly earnings report soon. Investors are watching closely, seeking signs that the company has not only met but exceeded expectations. According to forecasts, analysts predict an earnings per share (EPS) of approximately $0.05. This announcement is set to stir...
Continue Reading
Investigating Simulations Plus, Inc. for Securities Fraud Recent events have raised significant concerns regarding the financial practices of Simulations Plus, Inc. (NASDAQ: SLP), a prominent software firm specializing in the pharmaceutical and biotechnology sectors. This article explores the unfolding situation, which has financial implications for investors closely...
Continue Reading
NEXE Innovations Reports Strong Growth and Key Milestones NEXE Innovations Inc. (TSXV: NEXE) has recently released its financial results for the quarter that ended in August 2025. The company is making strides in the compostable materials sector and has showcased impressive growth metrics and operational achievements. Financial Highlights for Q1 2026 For the three-month...
Continue Reading